ATLANTA–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of cloud-based, ambulatory-focused technology solutions, will host its 2022 Investor Event on Tuesday, May 3, 2022, at the Nasdaq MarketSite in New York City from 10:00 a.m. to 12:00 p.m. The meeting will be held in person, and in addition, the company will broadcast the event live.
Program highlights will include sessions led by the following key executives:
How to Participate
In order to participate, we ask all investors register using the following link: https://edge.media-server.com/mmc/p/sbo3bpwy or contact mscalo@nextgen.com.
For additional information about the event, supporting materials, and the live broadcast, please visit the NextGen Healthcare 2022 Investor Day site at https://investorevent22.nextgen.com/ or visit the NextGen Healthcare investor webpage on investor.nextgen.com. The presentation will be archived for 90 days.
About NextGen Healthcare, Inc.
NextGen Healthcare, Inc. (Nasdaq: NXGN) is a leading provider of cloud-based ambulatory-focused technology solutions. We are empowering the transformation of ambulatory care—partnering with medical, behavioral and dental providers in their journey to value-based care to make healthcare better for everyone. We go beyond EHR and PM. Our integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. We believe in better healthcare outcomes for all. Learn more at nextgen.com, and follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.
Contacts
Investor Relations Contact
Matthew Scalo
(415) 370-9202
mscalo@nextgen.com
At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response…
Objective response rate of 69.2% observed in heavily pretreated patient population including patients with BTK…
The study met its primary endpoint of overall survival with a 41% reduction in the…
DENVER, CO / ACCESSWIRE / June 15, 2024 / Each year over 120,000 Coloradans are…
REYKJAVIK, Iceland, June 15, 2024 /PRNewswire/ -- In a recent display of global baking talent,…
– ENERGIZE is the First Study to Demonstrate Efficacy of an Oral Treatment for Non-Transfusion-Dependent Alpha-…